Fibrillary Glomerulonephritis and Monoclonal Gammopathy: Potential Diagnostic Challenges

Yi Da1, Giap Hean Goh2, Titus Lau1

  • 1Division of Nephrology, Department of Medicine, National University Hospital, Singapore, Singapore.

Frontiers in Oncology
|June 13, 2022
PubMed

Insights

Distinguishing fibrillary glomerulonephritis (FGN) with monoclonal gammopathy of renal significance (MGRS) from incidental monoclonal gammopathy of undetermined significance (MGUS) is challenging. Recent findings suggest MGRS is rare in FGN, necessitating advanced diagnostic approaches.

Area of Science:

  • Nephrology
  • Pathology
  • Immunology

Background:

  • Fibrillary glomerulonephritis (FGN) is a rare kidney disease characterized by abnormal fibrils.
  • Monoclonal gammopathy is present in up to 10% of FGN patients, complicating diagnosis.
  • Current methods for demonstrating monoclonality in FGN are limited by sensitivity and availability.

Purpose of the Study:

  • To address the diagnostic challenges in differentiating FGN with monoclonal gammopathy of renal significance (MGRS) from FGN with incidental monoclonal gammopathy of undetermined significance (MGUS).
  • To highlight the limitations of current diagnostic techniques for assessing monoclonality in FGN.
  • To emphasize the rarity of MGRS in FGN based on recent studies.

Main Methods:

  • Review of current diagnostic limitations including immunofluorescence in frozen tissue (IF-F) vs. paraffin sections (IF-P), immunoglobulin G (IgG) subtyping, and VH/VL domain monoclonality tests.
  • Consideration of DnaJ homolog subfamily B member 9 (DNAJB9) as a diagnostic marker for FGN.
  • Analysis of recent studies summarizing the incidence of MGRS in FGN.

Main Results:

  • Current kappa staining by immunofluorescence in frozen tissue (IF-F) shows suboptimal sensitivity compared to pronase-digested paraffin sections (IF-P).
  • Limitations exist in the availability of IgG subtyping and tests for VH/VL domain monoclonality in clinical settings.
  • Recent research indicates that genuine MGRS is extremely rare among FGN patients.

Conclusions:

  • Accurate differentiation between FGN-MGRS and FGN with incidental MGUS requires improved diagnostic strategies.
  • The discovery of DNAJB9 offers a potential diagnostic tool for FGN, reducing reliance on electron microscopy (EM).
  • Further research integrating advanced techniques like IF-P, IgG subtyping, VH/VL domain analysis, and DNAJB9 is crucial for understanding FGN and MGRS.

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
25
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
21
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
9.8K
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
38